Latest & greatest articles for pregabalin

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on pregabalin or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on pregabalin and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for pregabalin

81. Lyrica (Pregabalin) Capsules

Lyrica (Pregabalin) Capsules Drug Approval Package: Lyrica (Pregabalin) NDA #021724 Drug Approval Package U.S. Food & Drug Administration Enter Search terms Drug Approval Package - Lyrica (Pregabalin) Capsules Company: Pfizer Inc. Application No.: 021724 Approval Date: 06/10/2005 (PDF) (PDF) Medical Review(s) (PDF) (PDF) (PDF) (PDF) (PDF) (PDF) (PDF) (PDF) (PDF) (PDF) Date created: January 23, 2008 Note: Documents in PDF format require the . - - Links on this page: Note: If you need help

FDA - Drug Approval Package2005

82. Lyrica (Pregabalin)

Lyrica (Pregabalin) Drug Approval Package: Lyrica (Pregabalin) NDA #021446 Drug Approval Package U.S. Food & Drug Administration Enter Search terms Drug Approval Package - Lyrica (Pregabalin) Capsules Company: Pfizer Gloval Research & Development Application No.: 021446 Approval Date: 12/30/2004 (PDF) (PDF) (PDF) (PDF) (PDF) (PDF) (PDF) Date created: July 192005 Note: Documents in PDF format require the . - - Links on this page: Note: If you need help accessing information in different file

FDA - Drug Approval Package2004